The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes.
The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes.
复制标题
cAMP-PGC1 α 通路引发的抗 Warburg 效应驱动胶质母细胞瘤细胞分化为星形胶质细胞
DOI:
10.1016/j.celrep.2016.12.037
复制
发表时间:
2017-01-10
期刊:
影响因子:
8.8
通讯作者:
Yan G
中科院分区:
文献类型:
--
作者:
Xing F;Luan Y;Cai J;Wu S;Mai J;Gu J;Zhang H;Li K;Lin Y;Xiao X;Liang J;Li Y;Chen W;Tan Y;Sheng L;Lu B;Lu W;Gao M;Qiu P;Su X;Yin W;Hu J;Chen Z;Sai K;Wang J;Chen F;Chen Y;Zhu S;Liu D;Cheng S;Xie Z;Zhu W;Yan G
Glioblastoma multiforme (GBM) is among the most aggressive of human cancers. Although differentiation therapy has been proposed as a potential approach to treat GBM, the mechanisms of induced differentiation remain poorly defined. Here, we established an induced differentiation model of GBM using cAMP activators that specifically directed GBM differentiation into astroglia. Transcriptomic and proteomic analyses revealed that oxidative phosphorylation and mitochondrial biogenesis are involved in induced differentiation of GBM. Dibutyryl cyclic AMP (dbcAMP) reverses the Warburg effect, as evidenced by increased oxygen consumption and reduced lactate production. Mitochondrial biogenesis induced by activation of the CREB-PGC1α pathway triggers metabolic shift and differentiation. Blocking mitochondrial biogenesis using mdivi1 or by silencing PGC1α abrogates differentiation; conversely, overexpression of PGC1α elicits differentiation. In GBM xenograft models and patient-derived GBM samples, cAMP activators also induce tumor growth inhibition and differentiation. Our data show that mitochondrial biogenesis and metabolic switch to oxidative phosphorylation drive the differentiation of tumor cells. In Brief Xing et al. show that the metabolic shift from glycolysis to oxidative phosphorylation drives differentiation of GBM cells into astrocytes by cAMP activation. Mechanistically, the cAMP-CREB-PGC1α signal mediates mitochondrial biogenesis, which leads to metabolic reprogramming, induced differentiation, and tumor growth inhibition.
登录
查看更多内容
DOI:
10.1093/bioinformatics/btu638
发表时间:
2015-01-15
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Anders S;Pyl PT;Huber W
通讯作者:
Huber W
DOI:
10.1038/nrm3772
发表时间:
2014-04
期刊:
Nature reviews. Molecular cell biology
影响因子:
--
作者:
通讯作者:
--
影响因子:
14.9
作者:
Flicek P;Amode MR;Barrell D;Beal K;Billis K;Brent S;Carvalho-Silva D;Clapham P;Coates G;Fitzgerald S;Gil L;Girón CG;Gordon L;Hourlier T;Hunt S;Johnson N;Juettemann T;Kähäri AK;Keenan S;Kulesha E;Martin FJ;Maurel T;McLaren WM;Murphy DN;Nag R;Overduin B;Pignatelli M;Pritchard B;Pritchard E;Riat HS;Ruffier M;Sheppard D;Taylor K;Thormann A;Trevanion SJ;Vullo A;Wilder SP;Wilson M;Zadissa A;Aken BL;Birney E;Cunningham F;Harrow J;Herrero J;Hubbard TJ;Kinsella R;Muffato M;Parker A;Spudich G;Yates A;Zerbino DR;Searle SM
通讯作者:
Searle SM
DOI:
10.1158/1078-0432.ccr-08-0827
发表时间:
2008-12-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Goldhoff P;Warrington NM;Limbrick DD Jr;Hope A;Woerner BM;Jackson E;Perry A;Piwnica-Worms D;Rubin JB
通讯作者:
Rubin JB
影响因子:
64.5
作者:
Hsu, Peggy P.;Sabatini, David M.
通讯作者:
Sabatini, David M.